Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 1998

View Archived Issues

Inspire enters into strategic partnership with Kissei

Pylorid-containing triple therapy effective in eradicating H. pylori

Matrix completes enrollment in IntraDose trials

Corixa's MUC-1 vaccine technology receives patent protection

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Positive clinical data from temozolomide trials presented at European oncology meeting

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Anthraquinone telomerase inhibitors developed at CRC Technology

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Organon designs novel acylguanidine-containing thrombin inhibitors

Joint venture for development of MPS I treatment now a reality

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Algos releases phase III clinical trial results for MorphiDex

Committee recommends approval of test to identify candidates for treatment with Herceptin

European-wide approval for Viagra

RPR will introduce CombiPatch in U.S. during third quarter

Novel treatment for breast cancer available for licensing

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

FDA clears diagnostic for DVT - a potentially life-threatening disorder

YM-75466 exerts antithrombotic effects at doses that do not alter bleeding and coagulation times

European marketing application for Myotrophin withdrawn

Bioniche receives EU registration for Cystistat

Biovail subsidiary will market clot buster in Canada

Cytogen's Cellcor subsidiary closes operations this week